Our data are in agreement with data from Sullivan et al. who confirmed that LF survivors from Sierra Leone and Nigeria showed a stronger LASV-NP-specific CD4+ than CD8+ T cell response [64]. The gene discussed is CD8A; the disease is Lassa fever.